pharmacyclics inc (PCYC:NASDAQ GS)
David D. Smith Ph.D.
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee, Pharmacyclics Inc.
|Age||Total Calculated Compensation||This person is connected to 22 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. David D. Smith, Ph.D. serves as a Principal Research Scientist for the Research and Development Division at Oncotech, Inc. Dr. Smith is responsible for investigating mechanisms of chemotherapeutic resistance. He serves as a Senior Biostatistician at City of Hope, where he has designed and analyzed over 50 solid tumor and hematology protocols at all levels of development, from pre-clinical and genomic studies to Phase II/III trials. Dr. Smith was instrumental in City ...
999 East Arques AvenuePhone: 408-774-0330
Sunnyvale, California 94085
Board Members Memberships*
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
University of California-Los Angeles
Texas A&M University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Jean-Paul Clozel M.D.||Founder, Chief Executive Officer, Member of Management Board and Director|
|David L. Hallal||Chief Executive Officer and Director|
Alexion Pharmaceuticals, Inc.
|Jan G. J. van de Winkel Ph.D.||Co-Founder, Chief Executive Officer and President|
|kr11.0M||Compensation as of Fiscal Year 2014.|